AMRX | tickerfilter.com

Fundamental analysis

32%

Profitability 16%

Dept financing 43%

Liquidity 57%

Performance 40%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

3.34%

1 Month

19.94%

3 Months

27.73%

6 Months

56.88%

1 Year

111.22%

2 Year

268.51%

Key data

Stock price

$8.65

P/E Ratio

-15.35

DAY RANGE

$8.55 - N/A

EPS

-$0.68

52 WEEK RANGE

$3.36 - $8.72

52 WEEK CHANGE

$1.05

MARKET CAP

2.681 B

YIELD

N/A

SHARES OUTSTANDING

309.543 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

11/11/2024

BETA

1.59

PUBLIC FLOAT

AVERAGE 10 VOLUME

$1,258,921

AVERAGE 30 VOLUME

$1,593,298

Company detail

CEO: Chirag K. Patel
Region: US
Website: https://www.amneal.com/
Employees: 3,712
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

an american pharmaceutical company, amneal develops and produces affordable medicines. the company was built upon a family tradition of quality and integrity. everything amneal does, across the full spectrum of its business, is in service to these guiding principles. amneal is committed to constantly elevating and refining the value it delivers to its customers and patients around the globe.

AMRX - Amneal Pharmaceuticals Inc - Ordinary Shares - Class A